Stock Price Quote

GLOBAL HEALTH LTD.

NSE : MEDANTABSE : 543654ISIN CODE : INE474Q01031Industry : Hospital & Healthcare ServicesHouse : Private
BSE1237.5541.75 (+3.49 %)
PREV CLOSE ( ) 1195.80
OPEN PRICE ( ) 1242.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4303
TODAY'S LOW / HIGH ( )1216.85 1258.00
52 WK LOW / HIGH ( )936.05 1510.1
NSE1238.1042.15 (+3.52 %)
PREV CLOSE( ) 1195.95
OPEN PRICE ( ) 1224.00
BID PRICE (QTY) 1238.10 (80)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 232914
TODAY'S LOW / HIGH( ) 1217.35 1260.00
52 WK LOW / HIGH ( )935.5 1511
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-08 2004
Management Info
Naresh Trehan - Chairman Naresh Trehan - Managing Director
Registered Office

Address Medanta- Mediclinic,E-18, Defence Colony,,
New Delhi,
Delhi-110024

Phone 011-44114411

Email info@medanta.org

Website www.medanta.org

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

08Apr Global Health gets offer from AEGCL to
Global Health has received an offer from Assam Electricity Grid Corporat..
08Apr Global Health soars on getting offer f
Global Health is currently trading at Rs. 1239.30, up by 43.50 points or..
01Mar Global Health informs about disclosure
In furtherance to earlier intimation dated February 21, 2025, Global Hea..
01Mar Global Health informs about analyst me
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obliga..
20Feb Global Health informs about disclosure
In furtherance, to its earlier intimation dated January 13, 2025, in res..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit993.0499999999993608.91
Gross Profit 1323.1 4886.71
Operating Profit 1616.96002.18
Net Sales 6244.0422800.08

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Vijaya Diagnostic (BSE)
peergroup  1020.90 (14.23%)
M.Cap ( in Cr)10830.18
RainbowChildrenS Med (BSE)
peergroup  1480.55 (5.49%)
M.Cap ( in Cr)15025.59
Apollo Hospital Ent. (BSE)
peergroup  6755.90 (1.15%)
M.Cap ( in Cr)97021.57
Dr. Lal Pathlabs (BSE)
peergroup  2536.45 (2.94%)
M.Cap ( in Cr)21169.61
Dr Agarwals Eye Hsp (BSE)
peergroup  4061.40 (1.46%)
M.Cap ( in Cr)1917.11

Shareholding Pattern

MUTUAL FUNDS/UTI 9%
NON-INSTITUTION 43.98%
PROMOTERS 33.03%
FI/BANKS/INSURANCE 0.66%
GOVERNMENT 0%
FII 0%

About Global Health Ltd.

Global Health Ltd. was incorporated in the year 2004. Its today's share price is 1237.55. Its current market capitalisation stands at Rs 33245.75 Cr. In the latest quarter, company has reported Gross Sales of Rs. 22800.08 Cr and Total Income of Rs.23828.76 Cr. The company's management includes Pankaj Prakash Sahni, Sunil Sachdeva, Vikram Singh Mehta, Ravi Kant Jaipuria, Ravi Gupta, Rajan Bharti Mittal, Praveen Mahajan, Hari Shanker Bhartia, Naresh Trehan, Naresh Trehan, Rahul Ranjan.

It is listed on the BSE with a BSE Code of 543654 , NSE with an NSE Symbol of MEDANTA and ISIN of INE474Q01031. It's Registered office is at Medanta- Mediclinic,E-18, Defence Colony,New Delhi-110024, Delhi. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Price Waterhouse Chartered Accountants LLP, Price Waterhouse Coopers, Walker Chandiok & Co LLP

1.NSE exchange is Stopping the facility of Stop-Loss Market (SL-M) orders In option trade from 27th Sept 2021 to avoid freak trades and reduce its impact significantly. 2. Introduction of T+1 rolling settlement on optional basis. Stock Exchange may choose to offer T+1 settlement cycle. There shall be no netting between T+1 and T+2 settlements. Circular provisions come into force with effect from Jan: @SEBI_India 3. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. 4. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 5. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Do not share sensitive information like User ID, Password, OTP, etc., with anyone. Regards, Nirmal Bang.
1.NSE exchange is Stopping the facility of Stop-Loss Market (SL-M) orders In option trade from 27th Sept 2021 to avoid freak trades and reduce its impact significantly. 2. Introduction of T+1 rolling settlement on optional basis. Stock Exchange may choose to offer T+1 settlement cycle. There shall be no netting between T+1 and T+2 settlements. Circular provisions come into force with effect from Jan: @SEBI_India 3. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. 4. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 5. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Do not share sensitive information like User ID, Password, OTP, etc., with anyone. Regards, Nirmal Bang.

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.
Close X
OPEN

DEMAT ACCOUNT

AND START YOUR

INVESTMENT

JOURNEY WITH US
(You will receive a Call & SMS from our end)
Popup-Character

Disclaimer: NIRMAL BANG SECURITIES PVT LTD: Investment in Securities market are subject to market risks. Read all the related documents carefully before investing. Please read the Do’s and Don’ts prescribed by the Commodity Exchange before trading. We do not offer PMS Service for the Commodity segment. Opening of account will not guarantee allotment of shares in IPO. Investors are requested to do their own due diligence before investing in any IPO. The securities quoted are exemplary and are not recommendatory. BSE (Member ID- 498): INB011072759, INF011072759, Exchange Registered Member in CDS; NSE MEMEBR ID- 09391): INB230939139, INF230939139, INE230939139; MSEI Member ID-1067): INB260939138, INF260939138, INE260939139: Single Registration No. INZ000202536, PMS Registration No: INP000002981; Research Analyst Registration No: INH000001766; NSDL/ CDSL: IN-DP-CDSL 37-99; Exchange Member ID: MCX - 56460, NCDEX - 1268, ICEX – 2073. Regd. Office: B-2, 301/302, 3rd Floor, Marathon Innova, Off Ganpatrao Kadam Marg, Lower Parel (W), Mumbai - 400013. Tel: 62738000/01; Fax: 62738010 | *NIRMAL BANG NIVESHALAYA PVT LTD: ARN – 111233, Mutual Fund Distributor. Mutual Fund Investments are subject to market risks. Please read the offer documents carefully before Investing.” Regd. Office: B - 201, Khandelwal House, Poddar Road, Near Poddar Park, Malad (East). Mumbai – 400097. | **NIRMAL BANG INSURANCE BROKING PVT LTD: IRDAI Registration No: 795 and Registration Code For the Insurance Broker: IRDAI/DB889/2021. Insurance is the subject matter of the solicitation. For more details on policy terms, conditions, exclusions, limitations, please refer/read policy brochure carefully before concluding sale.